NEW! eNET Study
We are conducting a new study to learn about symptoms and quality of life for patients with Neuroendocrine Tumors.
Center for Neuroendocrine Tumors
Offering comprehensive evaluations and personalized treatment plans, the Center for Neuroendocrine Tumors includes a multidisciplinary team that enables patients with any type of neuroendocrine tumor to receive expert, team-based care.
Who We Are
Offering comprehensive evaluations and personalized treatment plans, the Center for Neuroendocrine Tumors includes a multidisciplinary team that enables patients with any type of neuroendocrine tumor to receive expert, team-based care.

Our team includes surgeons, oncologists, interventional radiologists, nuclear medicine experts, cardiologists, endocrinologists, genetic counselors, nutritionists and symptom management specialists. This enables patients with any type of NET to receive expert, team-based care.
Personalized Treatment and Care
Promising new treatments for neuroendocrine tumors, such as Peptide Receptor Radionuclide Therapy (PRRT).

Offering comprehensive evaluations and personalized treatment plans, the Center for Neuroendocrine Tumors includes a multidisciplinary team that enables patients with any type of neuroendocrine tumor to receive expert, team-based care.


Conditions treated:

  • Pancreatic NETs
  • Well-differentiated tumors of the GI tract (stomach, small intestine, appendix, colon and rectum), kidney, ovaries and presacral space, as well as unknown primary NETs
  • Bronchial carcinoid
  • Thymic carcinoid
  • Small cell lung carcinoma
  • Large cell NEC of lung
  • Other poorly differentiated NECs (small and large cell NECs)
  • Well differentiated G3 NETs
  • Neuroendocrine prostate cancer (NEPC)
  • Merkel cell carcinoma
  • Paraganglioma/Pheochromocytoma
  • Adrenal Cortical Carcinoma
  • Medullary Thyroid Carcinoma
  • Mixed tumors (adenoneuroendocrine carcinomas, mixed acinar-neuroendocrine tumors, globlet cell carcinoid)

Featured Publications

Challenges Staging Neuroendocrine Tumors of the Pancreas, Jejunum and Ileum, and Appendix.  Nakakura EK.  Ann Surg Oncol. 2017 Aug 4. doi: 10.1245/s10434-017-6026-9. [Epub ahead of print]
 

The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society.  Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ, Law CH, Liu EH, Kim MK, Menda Y, Morse BG, Bergsland EK, Strosberg JR, Nakakura EK, Pommier RF.  Pancreas. 2017 Jul;46(6):715-731.
 

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors.   Strosberg JR, Halfdanarson TR, Bellizzi AM, Chan JA, Dillon JS, Heaney AP, Kunz PL, O'Dorisio TM, Salem R, Segelov E, Howe JR, Pommier RF, Brendtro K, Bashir MA, Singh S, Soulen MC, Tang L, Zacks JS, Yao JC, Bergsland EK.   Pancreas. 2017 Jul;46(6):707-714.